The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Active Ingredient: NAPROXEN
Proprietary Name: NAPROXEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code: Application Number: A077339
Product Number: 001
Approval Date: Apr 27, 2005
Applicant Holder Full Name: L PERRIGO CO
Marketing Status:
Discontinued
Patent and Exclusivity Information
Active Ingredient: NAPROXEN
Proprietary Name: NAPROXEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 375MG
Reference Listed Drug: No
Reference Standard: No
TE Code: Application Number: A077339
Product Number: 002
Approval Date: Apr 27, 2005
Applicant Holder Full Name: L PERRIGO CO
Marketing Status:
Discontinued
Patent and Exclusivity Information
Active Ingredient: NAPROXEN
Proprietary Name: NAPROXEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code: Application Number: A077339
Product Number: 003
Approval Date: Apr 27, 2005
Applicant Holder Full Name: L PERRIGO CO
Marketing Status:
Discontinued
Patent and Exclusivity Information